JNJ · Johnson & Johnson · Analyst Estimates
$270.56
-2.64 (-0.97%)
At close · Nov 2
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$657.68B
Shares
2.41B
Volume · Nov 2
8.3M
Avg daily vol (3M)
6.92M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Johnson & Johnson across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-29 20:32 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
11.05
|
11.12
|
11.28
|
21
|
11.12
|
11.07
|
11.05
|
11.68
|
1
|
2
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
101.00B
|
101.22B
|
101.47B
|
21
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
10.65
|
11.62
|
13.34
|
22
|
11.62
|
12.14
|
12.31
|
12.84
|
1
|
2
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
106.30B
|
107.75B
|
109.95B
|
21
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
2.86
|
2.92
|
2.97
|
17
|
2.92
|
2.97
|
3.03
|
3.03
|
1
|
2
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
26.23B
|
26.42B
|
26.68B
|
15
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
2.57
|
2.68
|
2.87
|
7
|
2.68
|
2.78
|
2.78
|
2.93
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
25.30B
|
25.55B
|
26.20B
|
6
|
— | — | — | — | — | — | — | — |
Key facts
CIK
200406
CUSIP
478160104
13F (30d)
2453 filings
2347 filers
Visit website
Investor relations